Maeve O’Huallachain is a Principal Scientist in Discovery focused on target identification and validation. Some of her projects include optimizing tissue dissociation protocols and developing multimodal single-cell analysis workflows. Before joining Cartography, she was a Scientific Manager in the Cellular and Tissue Genomics Department at Genentech. She holds a PhD in Molecular, Cellular, and Developmental Biology from Yale University. In her free time, she enjoys cycling, playing boardgames with her husband, and building Lego towers with her two sons.
Recent Posts
- Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
- Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
- Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
- Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
- Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
Recent Comments
No comments to show.